GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Deferred Policy Acquisition Costs

ArcticZymes Technologies ASA (FRA:B4V) Deferred Policy Acquisition Costs


View and export this data going back to . Start your Free Trial

What is ArcticZymes Technologies ASA Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


ArcticZymes Technologies ASA (FRA:B4V) Business Description

Traded in Other Exchanges
Address
Sykehusveien 23, Tromso, NOR, N-9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments that are Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA.